Table 4a.
Baseline health status scores for participants enrolled in the ISCHEMIA-CKD triala.
| Mean ± SD Median (IQR) |
Baseline BMI (kg/m) | P-Value | ||
|---|---|---|---|---|
| <25 (N = 235) | 25 to <30 (N = 226) | ≥30 (N = 241) | ||
| SAQ-7 Summary Score | 79.7 ± 17.6 82.8 (68.3, 95.8) |
75.6 ± 18.7 77.8 (60.0, 92.5) |
73.6 ± 20.7 75.0 (60.0, 93.8) |
0.004 |
| SAQ-7 Angina Frequency Score | 89.2 ± 14.6 100.0 (80.0, 100.0) |
86.4 ± 17.3 90.0 (80.0, 100.0) |
86.2 ± 19.9 90.0 (80.0, 100.0) |
0.28 |
| SAQ-7 Quality of Life Score | 69.3 ± 25.6 75.0 (50.0, 100.0) |
64.4 ± 27.4 62.5 (37.5, 87.5) |
65.1 ± 29.3 62.5 (37.5, 87.5) |
0.16 |
| SAQ-7 Physical Limitation Score | 81.3 ± 22.0 91.7 (66.7, 100.0) |
76.3 ± 23.2 83.3 (66.7, 100.0) |
67.6 ± 27.5 66.7 (50.0, 91.7) |
<0.001 |
| Rose Dyspnea Scale | 1.2 ± 1.4 1.0 (0.0, 2.0) |
1.4 ± 1.4 1.0 (0.0, 3.0) |
1.9 ± 1.5 2.0 (1.0, 4.0) |
<0.001 |
| EQ-5D Visual Analog Scale | 61.8 ± 17.0 60.0 (50.0, 75.0) |
63.7 ± 15.7 65.0 (50.0, 75.0) |
57.9 ± 19.7 60.0 (50.0, 70.0) |
0.007 |
Continuous variables compared using Kruskal-Wallis test.
Categorical variables compared using chi-square or Fisher’s exact test.